<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04265729</url>
  </required_header>
  <id_info>
    <org_study_id>MPR18TA23134</org_study_id>
    <nct_id>NCT04265729</nct_id>
  </id_info>
  <brief_title>Neocate In Infants and Children With Complex Conditions</brief_title>
  <acronym>NICC</acronym>
  <official_title>An Open-label, Explorative, Post Launch Study of Neocate Amino Acid-based Feeds to Evaluate Nutritional Status and Gastrointestinal Tolerance in Infants and Children With Complex Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutricia Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nutricia Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infants and young children up to 10 years of age with a complex condition involving the&#xD;
      gastrointestinal tract are at risk of poor nutritional status, including faltering growth.&#xD;
      Due to the complex condition, standard nutrition is often not tolerated and causes&#xD;
      gastrointestinal symptoms.&#xD;
&#xD;
      Formulas in which protein is replaced by its smallest elements, amino acids are easier for&#xD;
      the body to digest and absorb. These formulas might be tolerated better and reduce&#xD;
      gastrointestinal symptoms in infants and young children with complex conditions.&#xD;
&#xD;
      The objectives of the present, exploratory study are to gain clinical evidence related to the&#xD;
      nutritional status and gastrointestinal tolerance in infants and young children with complex&#xD;
      conditions receiving Neocate as their primary source of nutrition. Additional objectives are&#xD;
      to describe the nutritional and pharmacological management of these infants and young&#xD;
      children. Study duration for each participant will be 52 weeks at maximum.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exploratory: Weight</measure>
    <time_frame>0 weeks</time_frame>
    <description>Weight [in g/kg]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Weight</measure>
    <time_frame>4 weeks</time_frame>
    <description>Weight [in g/kg]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Weight</measure>
    <time_frame>16 weeks</time_frame>
    <description>Weight [in g/kg]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Weight</measure>
    <time_frame>52 weeks</time_frame>
    <description>Weight [in g/kg]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Length</measure>
    <time_frame>0 weeks</time_frame>
    <description>Length/height [in cm]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Length</measure>
    <time_frame>4 weeks</time_frame>
    <description>Length/height [in cm]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Length</measure>
    <time_frame>16 weeks</time_frame>
    <description>Length/height [in cm]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Length</measure>
    <time_frame>52 weeks</time_frame>
    <description>Length/height [in cm]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: head circumference</measure>
    <time_frame>0 weeks</time_frame>
    <description>head circumference (for children &lt;2 years of age) [in cm]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: head circumference</measure>
    <time_frame>4 weeks</time_frame>
    <description>head circumference (for children &lt;2 years of age) [in cm]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: head circumference</measure>
    <time_frame>16 weeks</time_frame>
    <description>head circumference (for children &lt;2 years of age) [in cm]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: head circumference</measure>
    <time_frame>52 weeks</time_frame>
    <description>head circumference (for children &lt;2 years of age) [in cm]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Biochemical markers of nutritional status</measure>
    <time_frame>0 weeks</time_frame>
    <description>Macronutrient, micronutrient and mineral levels in blood [in a.o. mmol/L]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Biochemical markers of nutritional status</measure>
    <time_frame>4 weeks</time_frame>
    <description>Macronutrient, micronutrient and mineral levels in blood [in a.o. mmol/L]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Biochemical markers of nutritional status</measure>
    <time_frame>16 weeks</time_frame>
    <description>Macronutrient, micronutrient and mineral levels in blood [in a.o. mmol/L]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Biochemical markers of nutritional status</measure>
    <time_frame>52 weeks</time_frame>
    <description>Macronutrient, micronutrient and mineral levels in blood [in a.o. mmol/L]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Gastrointestinal tolerance</measure>
    <time_frame>0 weeks</time_frame>
    <description>GastrointestinaI symptoms [none/mild/moderate/severe]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Gastrointestinal tolerance</measure>
    <time_frame>4 weeks</time_frame>
    <description>GastrointestinaI symptoms [none/mild/moderate/severe]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Gastrointestinal tolerance</measure>
    <time_frame>16 weeks</time_frame>
    <description>GastrointestinaI symptoms [none/mild/moderate/severe]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Gastrointestinal tolerance</measure>
    <time_frame>52 weeks</time_frame>
    <description>GastrointestinaI symptoms [none/mild/moderate/severe]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Stool frequency</measure>
    <time_frame>0 weeks</time_frame>
    <description>number of stools per day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Stool frequency</measure>
    <time_frame>4 weeks</time_frame>
    <description>number of stools per day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Stool frequency</measure>
    <time_frame>16 weeks</time_frame>
    <description>number of stools per day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Stool frequency</measure>
    <time_frame>52 weeks</time_frame>
    <description>number of stools per day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Stool consistency</measure>
    <time_frame>0 weeks</time_frame>
    <description>parent reported stool consistency using stool scales (scale depending on diaper use or not) with categories within the range hard to watery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Stool consistency</measure>
    <time_frame>4 weeks</time_frame>
    <description>parent reported stool consistency using stool scales (scale depending on diaper use or not) with categories within the range hard to watery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Stool consistency</measure>
    <time_frame>16 weeks</time_frame>
    <description>parent reported stool consistency using stool scales (scale depending on diaper use or not) with categories within the range hard to watery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Stool consistency</measure>
    <time_frame>52 weeks</time_frame>
    <description>parent reported stool consistency using stool scales (scale depending on diaper use or not) with categories within the range hard to watery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Nutrient intake</measure>
    <time_frame>0 weeks</time_frame>
    <description>calculated energy, protein and micronutrient levels from parent diary [in a.o. mg/d]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Nutrient intake</measure>
    <time_frame>4 weeks</time_frame>
    <description>calculated energy, protein and micronutrient levels from parent diary [in a.o. mg/d]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Nutrient intake</measure>
    <time_frame>16 weeks</time_frame>
    <description>calculated energy, protein and micronutrient levels from parent diary [in a.o. mg/d]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exploratory: Nutrient intake</measure>
    <time_frame>52 weeks</time_frame>
    <description>calculated energy, protein and micronutrient levels from parent diary [in a.o. mg/d]</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Complex Conditions, Including Impairment of the GI Tract</condition>
  <arm_group>
    <arm_group_label>single test product arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>use of Neocate Infant and Junior marketed products (product type depending on subject's age and condition)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Neocate Infant and Junior marketed products</intervention_name>
    <description>use of Neocate Infant and Junior marketed products</description>
    <arm_group_label>single test product arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infants and young children aged from 0 up to and including 10 years of age.&#xD;
&#xD;
          -  Severe impairment of at least 1 organ system&#xD;
&#xD;
          -  Impairment of the gastrointestinal tract, i.e. gastrointestinal disease, congenital&#xD;
             abnormality, surgical resection, or gastrointestinal dysfunction (including symptoms&#xD;
             of gastrointestinal dysmotility or malabsorption).&#xD;
&#xD;
          -  Receiving at least 75% of their energy intake from Neocate (Neocate Infant or Junior&#xD;
             powdered (marketed) product) at the time of study entry (V1).&#xD;
&#xD;
          -  Expected to receive at least 75% of their energy intake from the study product for at&#xD;
             least 4 weeks from study entry (V1).&#xD;
&#xD;
          -  Written informed consent provided by parents/guardians and assent by the child, if&#xD;
             applicable, according to local law.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Infants born with a gestational age &lt;37 weeks that are &lt;40 weeks corrected age at the&#xD;
             time of study entry (V1).&#xD;
&#xD;
          -  Infants or children with endoscopically confirmed eosinophilic oesophagitis and&#xD;
             prescribed an amino acid-based formula only for the management of the eosinophilic&#xD;
             oesophagitis.&#xD;
&#xD;
          -  Infants or children with a medical diagnosis that includes only (suspected) cow's milk&#xD;
             allergy and/or multiple food allergy.&#xD;
&#xD;
          -  Infants or children with renal dysfunction, e.g. acute or chronic kidney failure or&#xD;
             kidney cancer.&#xD;
&#xD;
          -  Infants or children with thyroid disorder or parathyroid disorder.&#xD;
&#xD;
          -  Expected to receive parenteral nutrition during intervention from study entry (V1).&#xD;
&#xD;
          -  Participation in any other studies involving investigational or marketed products&#xD;
             concomitantly or within 1 month prior to study entry (V1).&#xD;
&#xD;
          -  Investigator's uncertainty about the willingness or ability of the parents/guardians&#xD;
             to comply with the protocol requirements.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Danone Nutricia Research</last_name>
    <phone>+31 30 295000</phone>
    <email>register.clinicalresearchnutricia@danone.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>GI Care for Kids</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Dr. B. Gold</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prisma Health - Upstate</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Dr. M. Dougherty</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. von Haunersches LKinderspital</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Prof. Dr. S. Koletzko</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Great Ormond Street Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>Dr. O. Borrelli</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 28, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2020</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

